With respect to pathogenesis, some studies have proposed that the expression of TGF-β, TGF-βR1 and TGF-βR2 is increased in the skin cells of SSc patients, indicating that TGF-β may play a role in SSc skin lesions14. This evidence concerns the gene TGFBR2 and systemic sclerosis.